Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Capital Expenditures (2020 - 2026)

PROCEPT BioRobotics has reported Capital Expenditures over the past 7 years, most recently at $1.1 million for Q1 2026.

  • Quarterly Capital Expenditures fell 42.21% to $1.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.6 million through Mar 2026, up 428.06% year-over-year, with the annual reading at $9.4 million for FY2025, 2588.51% up from the prior year.
  • Capital Expenditures was $1.1 million for Q1 2026 at PROCEPT BioRobotics, down from $1.8 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $8.4 million in Q2 2023 and troughed at -$6.0 million in Q4 2023.
  • The 5-year median for Capital Expenditures is $866000.0 (2022), against an average of $898882.4.
  • The largest YoY upside for Capital Expenditures was 10923.08% in 2023 against a maximum downside of 789.84% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $866000.0 in 2022, then tumbled by 789.84% to -$6.0 million in 2023, then skyrocketed by 51.67% to -$2.9 million in 2024, then skyrocketed by 164.08% to $1.8 million in 2025, then crashed by 42.65% to $1.1 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Capital Expenditures are $1.1 million (Q1 2026), $1.8 million (Q4 2025), and $6.9 million (Q3 2025).